Skip to content
Research Article Open access CC BY 4.0

Post-Artesunate Late Haemolytic Anemia in a 17-Month-Old Infant Followed for Severe Malaria at the Yalosase Health Center, Isangi, DR Congo

Dieudonné Lobela Bumba, Issa Yakusu Issa, Ossinga Bassandja, Mankulu N’Sila, Beatrice Lisimo, Bruce Wembolua Shinga, Kendewa sabiti, Bokanga Ekelenge, Francy Baelongandi Folo, Atoba Bokele

Asian Journal of Case Reports in Medicine and Health · pp. 200–203 · Published 28 Dec 2021

Abstract

Artesunate is an artemisinin derivative with rapid and potent parasiticidal power. However, cases of delayed hemolytic anemia described in the literature can be fatal, especially in children. We report a rare case of late hemolytic anemia in an infant. This was a 17 month old infant with a history of severe malaria treated with artesunate two weeks ago, seen in consultation for hemolytic anemia with negative GE. Both HBsAg and anti-HCV serology were negative. Considering the context, the diagnosis of post-artesunate late hemolytic anemia was retained and the patient had progressed well after transfusion.

Late hemolytic anemia severe malaria artesunate injection Isangi

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.